GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SLM · Sep 30, 2024

SLM Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001628280-24-043447Bank
Sequential deposit growth80thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

3.38% · CORE · VALID

Net-income growth0thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-253.76% · CORE · VALID

Interest-income growth35thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

0.06% · CORE · VALID

Cash and equivalents60thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$4.5B · CORE · VALID

Sequential loan growth75thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

8.17% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History43 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-0.76%
Current
3.38%
Delta
4.14%
Earnings Growth Decreased
Previous
-4.93%
Current
-253.76%
Delta
-248.83%
Interest Income Growth Decreased
Previous
1.19%
Current
0.06%
Delta
-1.13%
Liquidity Decreased
Previous
$5.3B
Current
$4.5B
Delta
-$772.9M
Loan Growth Increased
Previous
-6.36%
Current
8.17%
Delta
14.53%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.